Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 4:10 pm Sale | 2025-09-30 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 4,748,327 5.100% | -176,387 (-3.58%) | Filing History |
| 2025-11-12 3:35 pm Sale | 2025-09-30 | 13G | Myriad Genetics, Inc. MYGN | Barclays PLC | 3,939,238 4.230% | -960,713 (-19.61%) | Filing History |
| 2025-10-31 11:05 am Sale | 2025-09-30 | 13G | Myriad Genetics, Inc. MYGN | VANGUARD GROUP INC | 7,882,515 8.470% | -1,374,978 (-14.85%) | Filing History |
| 2025-08-14 7:38 pm Sale | 2025-06-30 | 13G | Myriad Genetics, Inc. MYGN | DISCIPLINED GROWTH INVESTORS INC /MN | 753,956 0.800% | -3,539,020 (-82.44%) | Filing History |
| 2025-08-12 4:06 pm Purchase | 2025-06-30 | 13G | Myriad Genetics, Inc. MYGN | Barclays PLC | 4,899,951 5.310% | 4,899,951 (New Position) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | Myriad Genetics, Inc. MYGN | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | -4,592,264 (Position Closed) | Filing History |
| 2025-08-04 4:05 pm Purchase | 2025-06-30 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 4,924,714 5.300% | 380,564 (+8.37%) | Filing History |
| 2025-07-29 1:54 pm Sale | 2025-06-30 | 13G | Myriad Genetics, Inc. MYGN | VANGUARD GROUP INC | 9,257,493 10.040% | -696,740 (-7.00%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Myriad Genetics, Inc. MYGN | BlackRock Inc. BLK | 14,105,009 15.300% | -553,340 (-3.77%) | Filing History |
| 2025-05-15 4:36 pm Purchase | 2025-03-31 | 13G | Myriad Genetics, Inc. MYGN | DISCIPLINED GROWTH INVESTORS INC /MN | 4,292,976 5.100% | 4,292,976 (New Position) | Filing History |
| 2025-05-12 10:44 am Sale | 2025-03-31 | 13G | Myriad Genetics, Inc. MYGN | WELLINGTON MANAGEMENT GROUP LLP | 4,592,264 5.000% | -1,412,334 (-23.52%) | Filing History |
| 2025-02-14 08:32 am Sale | 2024-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 3,100,000 3.410% | -4,535,000 (-59.40%) | Filing History |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | Myriad Genetics, Inc. MYGN | WELLINGTON MANAGEMENT GROUP LLP | 6,004,598 6.600% | -1,215,108 (-16.83%) | Filing History |
| 2024-11-14 4:16 pm Sale | 2024-09-30 | 13G | Myriad Genetics, Inc. MYGN | GLENVIEW CAPITAL MANAGEMENT LLC | 1,261,530 1.390% | -4,022,452 (-76.13%) | Filing History |
| 2024-05-01 4:21 pm Purchase | 2024-04-25 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 4,544,150 5.000% | 50,889 (+1.13%) | Filing History |
| 2024-04-25 4:18 pm Purchase | 2024-04-17 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 4,493,261 4.970% | 931,924 (+26.17%) | Filing History |
| 2024-03-18 4:39 pm Purchase | 2024-03-12 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (Asia) Pte. Ltd. | 4,262,021 4.700% | 4,262,021 (New Position) | Filing History |
| 2024-02-14 4:47 pm Purchase | 2023-12-31 | 13G | Myriad Genetics, Inc. MYGN | GLENVIEW CAPITAL MANAGEMENT LLC | 5,283,982 5.970% | 971,851 (+22.54%) | Filing History |
| 2024-02-14 08:24 am Purchase | 2023-12-31 | 13G | Myriad Genetics, Inc. MYGN | Camber Capital Management LP | 7,635,000 8.500% | 635,000 (+9.07%) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Myriad Genetics, Inc. MYGN | VANGUARD GROUP INC | 9,954,233 11.120% | 642,472 (+6.90%) | Filing History |